An FDA advisory panel recommended against using ecstasy as a treatment for PTSD. A Congressional subcommittee weighs reforming the 340B Drug Pricing Program. And a new study reports that drug shortages are more frequent and last longer. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
Comments (3)
More Episodes
All Episodes>>
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
